Wolverine Trading’s Outset Medical OM Stock Holding History

Wolverine Trading’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-713	Closed	-$12.5K	–	5513
2024 Q4	$12.5K	Buy	+713	New	+$8.9K	﹤0.01%	5143

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wolverine Trading's OM Position: Q3 2024 in Review

Wolverine Trading sold out of Outset Medical (OM) in Q3 2024, closing a stake of 738 shares — an estimated $42.6K sold.

Wolverine Trading first reported a position in OM in Q2 2024 and held it in 1 quarter. The position peaked at $42.6K in Q2 2024. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

Wolverine Trading reported no remaining Outset Medical position as of Q3 2024 after selling out during the quarter.
Wolverine Trading sold 738 Outset Medical shares in Q3 2024, an estimated $42.6K.
Wolverine Trading first reported a position in Outset Medical in Q2 2024 and held it in 1 quarter.
Wolverine Trading's Outset Medical position peaked at $42.6K in Q2 2024.
78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.